LFVN

Q: What is the price of LifeVantage (LFVN) today?

The current price of LifeVantage (LFVN) is $ 5.43, representing a -53.32% gain over the past year. The stock began the year trading around $ 6.16 and is currently priced at $ 5.43. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does LifeVantage (LFVN) pay dividends?

In the last year, LifeVantage (LFVN) distributed dividends in the month of March, totaling $ 0.05. The Dividend Yield for the last 12 months is 3.31%.

Q: Is LifeVantage (LFVN) a good investment?

LifeVantage (LFVN) is currently trading at $ 5.43 with a P/E ratio of 8.98%. This represents a 129% premium compared to its historical average P/E. Over the past year, the stock has gained -53.32 and paid $ 0.05 in dividends, resulting in a dividend yield of 3.31%. The total shareholder return over the same period was -53.32%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

LifeVantage Corporation

Price

$ 5.43

return (12m)

-53.32%

p/e

8.98

p/bv

2.14

DIVIDEND YIELD

3.31%

LFVN price

LFVN

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment LFVN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

27.76%

3 months

-0.49%

1 year

-53.32%

2 years

-14.15%

5 years

-13.64%

10 years

-35.23%

Fundamentals LFVN

review the fundamentals of LifeVantage shares

P/E

8.98

Sector: -4.09 Industry: -4.09

P/S (PSR)

0.34

Sector: -3.87 Industry: -3.87

P/BV

2.14

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

3.31%

Sector: - Industry: -

ROA

12.85%

Sector: -61.28% Industry: -61.28%

ROE

23.83%

Sector: -61.00% Industry: -61.00%

ROIC

3.47%

Sector: -2,142.55% Industry: -2,142.55%

NET MARGIN

3.74%

Sector: -39.07% Industry: -39.07%

GROSS MARGIN

78.75%

Sector: 37.83% Industry: 37.83%

OPERATING MARGIN

4.27%

Sector: -39.17% Industry: -39.17%

EV/EBITDA

5.94

Sector: -3.91 Industry: -3.91

EV/EBIT

7.88

Sector: -4.18 Industry: -4.18

PRICE-TO-ASSETS

1.15

Sector: 1.39 Industry: 1.39

BVPS

2.54

Sector: 1.88 Industry: 1.88

EPS

0.60

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

0.54

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.46

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

-0.16%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-4.75%

Sector: - Industry: -

FAIR VALUE OF LifeVantage ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 5.43

Fair Value

$ 0.00

Upside/Downside Return potential.

7.84%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LFVN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.01	6.74	25.92%	2.29%	$ 547.30 B	21.83%
PFE	19.27	1.61	8.35%	6.53%	$ 149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$ 365.48 B	5.79%
NVO	12.44	6.41	51.50%	4.25%	$ 194.87 B	33.05%
MRK	31.01	0.00	0.00%	2.96%	$ 277.04 B	13.59%
AZN	27.54	6.04	21.93%	1.73%	$ 286.16 B	17.19%
GILD	19.21	7.23	37.62%	2.42%	$ 163.51 B	28.90%
BMY	16.31	0.00	0.00%	4.29%	$ 118.65 B	15.01%
ZTS	18.71	15.01	80.25%	1.78%	$ 50.00 B	28.23%
REGN	16.49	2.32	14.08%	0.51%	$ 72.95 B	29.65%
HALO	23.82	154.63	649.21%	0.00%	$ 7.55 B	22.69%
AMGN	22.83	19.38	84.87%	2.93%	$ 178.10 B	20.96%
MCK	23.07	-1,011.36	-4,383.84%	0.39%	$ 100.12 B	1.09%
VRTX	27.24	5.77	21.18%	0.00%	$ 107.68 B	32.94%
HRMY	11.43	2.08	18.24%	0.00%	$ 1.81 B	18.27%
CAH	29.51	-17.17	-58.20%	1.05%	$ 45.88 B	0.62%
ADMA	17.04	5.25	30.78%	0.00%	$ 2.50 B	28.80%
BIIB	20.04	1.47	7.36%	0.00%	$ 27.50 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

LFVN Historical Dividends

current DY: 3.31%

5-year average DY: 4.50%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/02/2026	03/16/2026	0,04500000
Dividends	12/01/2025	12/15/2025	0,04500000
Dividends	09/08/2025	09/16/2025	0,04500000
Dividends	05/30/2025	06/13/2025	0,04500000
Dividends	03/03/2025	03/17/2025	0,04000000
Dividends	12/02/2024	12/16/2024	0,04000000
Dividends	09/09/2024	09/17/2024	0,04000000
Dividends	05/31/2024	06/14/2024	0,04000000
Dividends	03/01/2024	03/15/2024	0,03500000
Dividends	12/01/2023	12/15/2023	0,03500000
Dividends	09/08/2023	09/22/2023	0,43500000
Dividends	06/01/2023	06/15/2023	0,03500000
Dividends	03/01/2023	03/15/2023	0,03000000
Dividends	12/01/2022	12/15/2022	0,03000000
Dividends	09/02/2022	09/15/2022	0,03000000
Dividends	05/17/2022	05/31/2022	0,03000000

ABOUT LifeVantage

LifeVantage Corporation

Average Investor10 user rating

4.0 (3 people)

United States

38 years

Founded: 1988

1997

Time since IPO - 29 years

247

Employees

LifeVantage Corporation (United States) is listed on the Nasdaq and has a market capitalization of $70.59 Millions, with shareholders equity totaling $32.99 Millions.

The company employs approximately 247 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, LifeVantage Corporation reported $210.04 Millions in revenue, generating net income of $7.86 Millions.

Key financial metrics include a P/E ratio of 8.98, a price-to-book (P/B) ratio of 2.14, and a trailing twelve-month dividend yield of 3.31%.

The company trades under the ticker LFVN.

Market cap

$ 70.59 Millions

Net worth

$ 32.99 Millions

$ 32,990,000.00

Assets

$ 61.17 Millions

$ 61,170,000.00

Total Shares Outstanding

13.00 Millions

13,000,000

Average Daily Trading Volume

$ 145.38 Thousand

$ 145,376.32

Sector

Health Care

Industry

Biotechnology

LFVN

LFVN revenue and profits

Financial Results LFVN

DRAG THE FRAME TO SEE MORE DATA

LFVN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 814.02 15,48% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$ 195.24 32,04% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$ 227.19 50,46% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$ 26.33 18,64% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$ 112.16 39,74% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 184.74 30,42% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$ 206.60 8,40% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 814.02 15,48% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$ 195.24 32,04% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$ 227.19 50,46% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$ 26.33 18,64% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$ 112.16 39,74% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 184.74 30,42% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$ 206.60 8,40% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of LifeVantage (LFVN) today?

The current price of LifeVantage (LFVN) is $ 5.43, representing a -53.32% gain over the past year. The stock began the year trading around $ 6.16 and is currently priced at $ 5.43. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does LifeVantage (LFVN) pay dividends?

In the last year, LifeVantage (LFVN) distributed dividends in the month of March, totaling $ 0.05. The Dividend Yield for the last 12 months is 3.31%.

Is LifeVantage (LFVN) a good investment?

LifeVantage (LFVN) is currently trading at $ 5.43 with a P/E ratio of 8.98%. This represents a 129% premium compared to its historical average P/E. Over the past year, the stock has gained -53.32 and paid $ 0.05 in dividends, resulting in a dividend yield of 3.31%. The total shareholder return over the same period was -53.32%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy LifeVantage (LFVN) stock?

You can buy LifeVantage (LFVN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LFVN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of LifeVantage (LFVN) yield today?

Over the past month, LifeVantage (LFVN) has returned 27.76% — -53.32% over the past year, and -13.64% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.18 per share in dividends, resulting in a dividend yield of 3.31%.

If you were to purchase 100 shares of LifeVantage (LFVN) today at the current price of $ 5.43 your total investment would be $ 543.00.

Based on historical performance, the investment would have grown to approximately:

$ 253.47 after 1 year
$ 468.93 after 5 years
$ 351.70 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LFVN

LifeVantage Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LFVN

review the fundamentals of LifeVantage shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 3.31%

5-year average DY: 4.50%

type

Ex - Dividend Date

payment date

value

ABOUT LifeVantage

LifeVantage Corporation

United States

38 years

1997

247

PROFIT X PRICE LFVN

Financial Results LFVN

LFVN cash flow

Asset, Revenue and Profit Growth - LFVN

LFVN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

Frequently Asked Questions